Wu D - Search Results

1

Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.

Wang G, Wang J, Chang A, Cheng D, Huang S, Wu D, Sirkisoon S, Yang S, Lin HK, Lo HW, Xiang R, Sun P. Wang G, et al. Among authors: wu d. Oncogene. 2020 Nov;39(47):7034-7050. doi: 10.1038/s41388-020-01481-y. Epub 2020 Sep 28. Oncogene. 2020. PMID: 32989258 Free PMC article.

2

Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by Wip1 inhibition.

Wang J, Wang G, Cheng D, Huang S, Chang A, Tan X, Wang Q, Zhao S, Wu D, Liu AT, Yang S, Xiang R, Sun P. Wang J, et al. Among authors: wu d. Oncogene. 2020 Oct;39(40):6313-6326. doi: 10.1038/s41388-020-01437-2. Epub 2020 Aug 26. Oncogene. 2020. PMID: 32848211 Free PMC article.

3

Correction to: Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.

Wang G, Wang J, Chang A, Cheng D, Huang S, Wu D, Sirkisoon S, Yang S, Lin HK, Lo HW, Xiang R, Sun P. Wang G, et al. Among authors: wu d. Oncogene. 2021 Mar;40(12):2335. doi: 10.1038/s41388-021-01652-5. Oncogene. 2021. PMID: 33568787 No abstract available.

4

MZF1 mediates oncogene-induced senescence by promoting the transcription of p16^INK4A.

Wu D, Tan H, Su W, Cheng D, Wang G, Wang J, Ma DA, Dong GM, Sun P. Wu D, et al. Oncogene. 2022 Jan;41(3):414-426. doi: 10.1038/s41388-021-02110-y. Epub 2021 Nov 12. Oncogene. 2022. PMID: 34773072 Free PMC article.

5

Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer.

Chang A, Liu L, Ashby JM, Wu D, Chen Y, O'Neill SS, Huang S, Wang J, Wang G, Cheng D, Tan X, Petty WJ, Pasche BC, Xiang R, Zhang W, Sun P. Chang A, et al. Among authors: wu d. Cancer Res. 2021 Jun 15;81(12):3358-3373. doi: 10.1158/0008-5472.CAN-21-0688. Epub 2021 Apr 14. Cancer Res. 2021. PMID: 33853832 Free PMC article.

6

Protein expression alteration in hippocampus upon genetic repression of AMPKα isoforms.

Yang W, Zhou X, Wang X, Lee J, Wu D, Sun P, Furdui CM, Ma T. Yang W, et al. Among authors: wu d. Hippocampus. 2021 Apr;31(4):353-361. doi: 10.1002/hipo.23305. Epub 2021 Jan 25. Hippocampus. 2021. PMID: 33492732 Free PMC article.

7

OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma.

Wu D, Yang X, Peng H, Guo D, Zhao W, Zhao C, Zhou X. Wu D, et al. Carcinogenesis. 2017 Sep 1;38(9):910-919. doi: 10.1093/carcin/bgx073. Carcinogenesis. 2017. PMID: 28911005 Free PMC article.

8

The role of SH3GL3 in myeloma cell migration/invasion, stemness and chemo-resistance.

Chen R, Zhao H, Wu D, Zhao C, Zhao W, Zhou X. Chen R, et al. Among authors: wu d. Oncotarget. 2016 Nov 8;7(45):73101-73113. doi: 10.18632/oncotarget.12231. Oncotarget. 2016. PMID: 27683032 Free PMC article.

9

Systemic modeling myeloma-osteoclast interactions under normoxic/hypoxic condition using a novel computational approach.

Ji Z, Wu D, Zhao W, Peng H, Zhao S, Huang D, Zhou X. Ji Z, et al. Among authors: wu d. Sci Rep. 2015 Aug 18;5:13291. doi: 10.1038/srep13291. Sci Rep. 2015. PMID: 26282073 Free PMC article.

10

Predicting the impact of combined therapies on myeloma cell growth using a hybrid multi-scale agent-based model.

Ji Z, Su J, Wu D, Peng H, Zhao W, Nlong Zhao B, Zhou X. Ji Z, et al. Among authors: wu d. Oncotarget. 2017 Jan 31;8(5):7647-7665. doi: 10.18632/oncotarget.13831. Oncotarget. 2017. PMID: 28032590 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,006 results

Search Page

Filters